← Back to catalogue

Tinto Myeloperoxidase/MPO (BSB-180)

FDA UDI

Class I (US FDA UDI)

by Bio Sb, Inc.

Identity

Trade Name
Tinto Myeloperoxidase/MPO (BSB-180) FDA UDI
Generic Name
Leukocyte myeloperoxidase (MPO) IVD, antibody FDA UDI
Device Name
Tinto Myeloperoxidase/MPO is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5 FDA UDI
Model / Reference
BSB-3828-7 FDA UDI
Description
Tinto Myeloperoxidase/MPO is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5 FDA UDI

Identifiers

Catalog Number
BSB-3828-7 FDA UDI
Primary DI / UDI-DI
B502BSB382870 FDA UDI
FDA Product Code
NJT FDA UDI
GMDN Term
Leukocyte myeloperoxidase (MPO) IVD, antibody FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 7 Milliliter FDA UDI

Category: Leukocyte myeloperoxidase (MPO) IVD, antibody

Tinto Myeloperoxidase/MPO (BSB-180) by Bio Sb, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Leukocyte myeloperoxidase (MPO) IVD, antibody.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Bio Sb, Inc.

Sources (1)

  • FDA UDI 4e06cbb5-66c9-4fda-8923-6c8e613f9c72 37 fields · synced Jun 6, 2026